Fractionated intravenous administration of 90Y-labeled B72.3 GYK-DTPA immunoconjugate in beagle dogs
- 31 July 1993
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 20 (5) , 571-578
- https://doi.org/10.1016/0969-8051(93)90025-p
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Preclinical evaluation of intravenously administered 111in- and 90y-labeled b72.3 immunoconjugate (GYK-DTPA) in beagle dogsNuclear Medicine and Biology, 1993
- Selection of reagents for human radioimmunotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Clinical Pharmacology, Metabolism, and Tissue Distribution of 90Y-Labeled Monoclonal Antibody B72.3 After Intraperitoneal AdministrationJNCI Journal of the National Cancer Institute, 1991
- Response of glioblastoma cell lines to low dose rate irradiationInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Advantage of Dose Fractionation in Monoclonal Antibody-Targeted RadioimmunotherapyJNCI Journal of the National Cancer Institute, 1990
- Factors controlling the engraftment of transplanted dog bone marrow cellsTissue Antigens, 1982